Focused on early-stage investments in the biotechnology and healthcare sectors across North America and Europe. Known for a disciplined investment approach, having executed over 50 deals with multiple successful exits. Specializes in high-potential startups that leverage innovative technologies to address unmet medical needs. Backed by a strong network of industry experts, emphasizing a collaborative strategy to enhance portfolio company growth.